- Super User
- Progress
- Read Time: 1 min
- Hits: 0
Our Study Site ranked 6th in the world in recruiting patients to study 14-433 to evaluate the efficacy and safety of the drug ABT-494 in patients with Crohn's disease.
- Super User
- Progress
- Read Time: 1 min
- Hits: 0
The selection for clinical trials RPC 01-3202 / RPC 01-3203 / RPC 01-3204 of phase III has been successfully completed. The purpose of the study: to evaluate the efficacy and safety of a new oral IP for patients with moderate or severe Crohn's disease.
- Super User
- Progress
- Read Time: 1 min
- Hits: 0
Our clinical trial department took the first place in Russia and entered the TOP 10 in the world for the Crohn’s disease clinical trial patients’ enrollment.
Our partners
